Connect with George Kouvas
George has long experience in industrial environments where he brought complex systems to market. He is passionate about helping the community bring technical innovations to life with the goal to improve the lives of people with nervous system disorders.
George Kouvas joined the Wyss Center in February 2017 and was appointed as CTO in January 2020. With over 20 years of experience in medical devices, neurotechnology, pharma, eHealth, eBusiness and R&D services, Kouvas holds a Diploma in Electrical and Computer Engineering and an MBA, from the National Technical University of Athens (NTUA).
As CTO, George is responsible for the development and translation of the Wyss Center’s technology portfolio towards the clinic and the market. Under his leadership, one of the Wyss Center’s flagship programs, EPIOS™, evolved from initial idea to clinical-stage start-up, while other technology projects are being accelerated for human benefit.
George enjoys acting as an expert and evaluating technology innovation projects and proposals. He is passionate about helping the community bring innovations to life.
Prior to joining the Wyss Center, he was a Director and Technical leader of Merck’s eHealth platform in Switzerland, where he managed the development and market-launch of disease management solutions for several therapeutic areas. Earlier in his career he held various engineering and management roles, coordinating consortiums of technology, business and academia partners in innovation projects.
Subscribe to our updates
Wyss Center announces new collaboration to improve brain tumor treatment
Translational project will create the first detailed 3D maps of human glioblastomas with an integrated ‘tissue time machine’ to predict response to therapies.Collaboration
Wyss Center announces CE mark for its brain data visualization software, Epios Cloud
The cloud-based platform enables long-term brain monitoring towards personalized treatment.Technology
EPFL and the Wyss Center award two new entrepreneurial projects
Selected for outstanding innovation and potential for impact, the EPFL-based entrepreneurs will collaborate with the Wyss Center to accelerate commercialization of their technologies.Collaboration